Nebenwirkungen · Visudyne
Visudyne 15 mg powder for solution for infusion · Abschnitt 4.8 · PDF-Seite 6
HOS-091166 · Präparat HOS-084217
The following adverse reactions were considered potentially related to Visudyne therapy. The adverse reactions are listed by system organ class and frequency using the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2020-09-16T02:00:00Z · SHA-256 3a3a3265d23eb5f145bd1d9db856c217528e19c50286f67e0a8227d1e7e2b879 · Passage 4640f494283385f5cd96730620df7a14faf61f6c7d8c905102b1f276ca9eb9c1 · Zeichen 548–1025 im Abschnitt